![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Bentham Science Publishers
E-ISSN: 1876-1038|4|2|131-139
ISSN: 1574-8871
Source: Reviews on Recent Clinical Trials, Vol.4, Iss.2, 2009-05, pp. : 131-139
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Doxorubicin variants for hematological malignancies
By Visani Giuseppe Isidori Alessandro
Nanomedicine, Vol. 6, Iss. 2, 2011-02 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Ifosfamide in Hematological Malignancies of Adults
Oncology, Vol. 65, Iss. 2, 2003-11 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Impact of Interleukin-6 in Hematological Malignancies
Transfusion Medicine and Hemotherapy, Vol. 40, Iss. 5, 2013-07 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Minimal Residual Disease in Hematological Malignancies
Acta Haematologica, Vol. 112, Iss. 1-2, 2004-06 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Non-Lymphoma Hematological Malignancies in Systemic Lupus Erythematosus
Oncology, Vol. 85, Iss. 4, 2013-10 ,pp. :